This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Thioplex

Amgen, Inc.

Drug Names(s): thiotepa

Description: Thiotepa is an alkylating chemotherapeutic agent that has been used for many years. Thioplex is lyophilized (freeze-dried) formulation that gives thiotepa a longer shelf life.

Deal Structure: Thioplex was developed by Immunex.

American Cyanamid Company became an Immunex majority stockholder in 1993.

In 1994, American Home Products acquired American Cyanamid Company.

In March 2002, American Home Products changed its name to Wyeth.

In July 2002, Amgen completed its acquisition of Immunex.


Thioplex News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug